bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.64898/2026.03.10.710870

Epstein-Barr virus induced epigenetic reprogramming drives cancer stem cell emergence in breast cancer

Friedenson, B. A.
View original source ↗Export metadata ↓

Abstract

Basal breast cancers display stem cell associated basal programs, but originate from luminal progenitors. This lineage paradox may be created by Epstein-Barr virus (EBV) infection. Across more than 2,000 breast cancer genomes, coordinated methyla-tion changes appeared in cis-regulatory elements governing stem cell differentiation. Methylation positions followed EBV-associated malignancies with striking accuracy independent of whether ER-status marked a luminal or basal cancer. EBV-driven epigenetic reprogramming was incompatible with tumor infiltrating lymphocytes and disrupted lineage specification before tumorigenesis. Breast cancers commonly showed coordinated viral response indicators that tracked with antigen presentation and stem cell differentiation programs. Non-malignant keratinocytes with resolved EBV infections retained some aberrantly methylated loci. Analyses of non-EBV skin carcinoma, randomized genomic sites, endogenous retroelements, DUX4, and repli-cation clocks confirmed the specificity of EBV-linked alterations. These findings posi-tion EBV as a developmental lineage hijacker that reprograms cells into premalignant stem-like states. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=107 SRC="FIGDIR/small/710870v1_ufig1.gif" ALT="Figure 1"> View larger version (26K): org.highwire.dtl.DTLVardef@13c8d52org.highwire.dtl.DTLVardef@620426org.highwire.dtl.DTLVardef@fe9a96org.highwire.dtl.DTLVardef@156f170_HPS_FORMAT_FIGEXP M_FIG C_FIG EBV infection reprograms the methylome of breast luminal progenitors to generate or select for cancer stem-like cells. In BriefEpstein-Barr virus (EBV) rewires developmental programs that specify cell identity, creating cancer stem-like cells with malignant potential. This targeted reshaping of progenitors links viral infection to the earliest steps of breast cancer development. HighlightsO_LIEpstein-Barr virus (EBV) infection reprograms the methylome of lu-minal progenitors generating breast cancer stem-like cells. C_LIO_LIEBV-driven methylation sites overlap luminal and basal breast cancer signatures that regulate stem cell differentiation. C_LIO_LICharacteristic responses to viral infection are common in breast can-cer and they correlate with gene programs needed to differentiate progenitor cells. C_LIO_LIEven after viral clearance, EBV leaves persistent methylation scars in non-malignant cells that may increase risks for future malignancy. C_LI

Explore related subjects

cancer biologyPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Friedenson, B. A.. 2026-03-12. Epstein-Barr virus induced epigenetic reprogramming drives cancer stem cell emergence in breast cancer. https://doi.org/10.64898/2026.03.10.710870

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Tissue resident CD4+ memory T-cells mark response to immune checkpoint inhibition in high-grade glioma

Background: Immune checkpoint inhibitors (ICI) are efficacious in many solid tumors, but response in glioma is restricted to a small subgroup. The determinants of response and resistance to ICI remain poorly understood. Methods: Here we exploit a syngeneic hypermutated high-grade glioma model with dichotomous response to combined PD-1 and CTLA-4 inhibition to unravel determinants of tumor-infiltrating T-cells driving response. Tumor-infiltrating T-cells from ICI-responsive and non-responsive tumors were analyzed by single-cell RNA and T-cell receptor sequencing and tumor-reactive T-cell receptor clonotypes were functionally validated to characterize their transcriptional phenotypes. We verify our findings in IDH1 wildtype glioblastoma patients treated with neoadjuvant pembrolizumab. Results: ICI response was associated with intratumoral clonal expansion of tumor-reactive cytotoxic T-cells and increased infiltration of CXCR6+ CD4+ tissue resident memory T-cells (Trm). CD4 stem-like memory T-cells in responding tumors demonstrated elevated interferon responses, following trajectories toward clonally expanded Trm, versus trajectories toward exhaustion in non-responsive tumors. In responsive tumors, CD4+ Trm interacted with infiltrating CXCR3+ tumor-reactive and clonally expanded, yet transcriptionally versatile cytotoxic T-cells. Probing the post neoadjuvant ICI high-grade glioma patient tissue dataset, we confirmed increased CXCR6 expression in CD4+ T cells and the association of CD4+ Trm with prolonged overall survival. Conclusion: These findings identify CD4 tissue-resident memory T-cells as determinants of ICI response in IDH1 wildtype high-grade glioma and warrant their further investigation to improve immunotherapy outcomes.

cancer biology↗
bioRxiv2026

Circadian gene-network distortion in high-risk neuroblastoma across multiple biological reference contexts

Background: The circadian clock regulates cellular homeostasis, and its disruption has been implicated in aggressive neuroblastoma, particularly in tumours harbouring MYCN- amplification. However, it remains unclear whether alterations are restricted to individual clock genes or extend to circadian gene network coordination. We therefore examined circadian clock network disruption in adverse neuroblastoma across multiple biological contexts. Methods: We estimated circadian gene network dysregulation using Delta-CCD in tumours from two neuroblastoma cohorts (SEQC n=498 and Kocak n=649), comparing clinical features associated with outcome across canonical, adrenal-tissue matched, and developmental references. Robustness was assessed by cross-cohort meta-analysis and leave-one-gene-out analyses. Cox proportional hazards models adjusted for clinical covariates assessed association between individual clock gene expression patient outcome. Results: Delta-CCD was highest in tumours classified as high-risk (study-specific definition) across reference contexts in both cohorts. MYCN-amplified tumours showed a more reference-dependent pattern, strongest in adrenal context, while stage 4 tumours showed a similar but weaker pattern. Additional analyses supported the high-risk signal as a distributed network-level alteration rather than a single-gene phenomenon. Conclusions: High-risk neuroblastoma is characterised by robust disruption of coordinated clock gene network organisation across canonical and tissue-matched references, extending beyond individual clock genes. The extent of circadian dysregulation depends on the reference state used.

cancer biology↗
bioRxiv2026

BAP1 loss and PRAME expression converge to remodel the tumor-immune ecosystem during uveal melanoma progression

Uveal melanoma (UM) is characterized by a small number of recurrent genetic alterations that determine metastatic propensity. BAP1 loss and PRAME expression define the dominant prognostic axes in UM, yet how they promote malignant progression remains unclear. We profiled 190,535 cells from normal uvea, uveal nevus, primary and metastatic UM using single-cell transcriptomics, T cell receptor sequencing, spatial transcriptomics and isogenic perturbation models. Normal melanocytes, nevus cells and UM cells formed a transcriptional continuum marked by loss of differentiation and emergence of neural crest-like, stress-responsive, hypoxic-glycolytic and immune-interacting states. BAP1 loss and PRAME expression imposed distinct but convergent immunoregulatory programs, inducing interferon and TNF-NFkB signaling and MHC-I expression, with HLA-E showing the strongest response. These alterations were accompanied by macrophage and CD8+ T cell remodeling. PRAME-enriched tumor regions formed spatially organized niches enriched for macrophages and plasma cells. These findings define BAP1 loss and PRAME expression as distinct but convergent axes of tumor-immune coevolution and nominate HLA-E as a candidate mediator of immune resistance.

cancer biology↗